Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 32.67
(0.28%)
CNY 32.67
(0.28%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 116.82 Million CNY | -86.69% |
| 2022 | 914.34 Million CNY | -5.4% |
| 2021 | 966.52 Million CNY | 88.38% |
| 2020 | 513.08 Million CNY | 1491.88% |
| 2019 | 32.23 Million CNY | 42.95% |
| 2018 | 22.54 Million CNY | 429.14% |
| 2017 | 4.26 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 18.22 Million CNY | -59.09% |
| 2024 Q3 | 15.55 Million CNY | 0.4% |
| 2024 Q1 | 44.53 Million CNY | 73.09% |
| 2023 Q2 | 51.33 Million CNY | 267.84% |
| 2023 FY | 121.68 Million CNY | -86.69% |
| 2023 Q4 | 25.72 Million CNY | -0.26% |
| 2023 Q3 | 25.79 Million CNY | -49.75% |
| 2023 Q1 | 13.95 Million CNY | 111.03% |
| 2022 Q3 | -134.93 Million CNY | -145.87% |
| 2022 Q1 | 582.91 Million CNY | 347.59% |
| 2022 Q2 | 294.18 Million CNY | -49.53% |
| 2022 FY | 914.34 Million CNY | -5.4% |
| 2022 Q4 | -126.54 Million CNY | 6.21% |
| 2021 FY | 966.52 Million CNY | 88.38% |
| 2021 Q4 | 130.23 Million CNY | -25.96% |
| 2021 Q3 | 175.88 Million CNY | -54.55% |
| 2021 Q2 | 386.97 Million CNY | 41.53% |
| 2021 Q1 | 273.42 Million CNY | 203.55% |
| 2020 FY | 513.08 Million CNY | 1491.88% |
| 2020 Q4 | 90.07 Million CNY | 35.47% |
| 2020 Q3 | 66.49 Million CNY | -78.9% |
| 2020 Q2 | 315.19 Million CNY | 662.85% |
| 2020 Q1 | 41.31 Million CNY | 0.0% |
| 2019 FY | 32.23 Million CNY | 42.95% |
| 2018 FY | 22.54 Million CNY | 429.14% |
| 2017 FY | 4.26 Million CNY | 0.0% |